Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v3.24.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Aug. 31, 2024
Aug. 31, 2023
Operating expenses:    
General and administrative $ 1,604 $ 2,688
Research and development (24,046) 1,914
Depreciation 5 10
Total operating expenses (22,437) 4,612
Operating gain (loss) 22,437 (4,612)
Interest and other income (expense):    
Interest income 126  
Interest on convertible notes (1,165) (1,197)
Amortization of discount on convertible notes (125) (400)
Amortization of debt issuance costs   (366)
Loss on induced conversion (1,180) (2,004)
Finance charges (14) (912)
Loss on note extinguishment   (2,084)
(Loss) gain on derivatives (852) 4
Total interest and other expenses 3,210 6,959
Gain (loss) before income taxes 19,227 (11,571)
Income tax benefit 0 0
Net income (loss) $ 19,227 $ (11,571)
Income (Loss) per share:    
Income (Loss) per share, Basic $ 0.02 $ (0.01)
Income (Loss) per share, Diluted $ 0.02 $ (0.01)
Weighted average common shares used in calculation of income (loss) per share:    
Weighted average common shares outstanding, Basic 1,135,043 923,587
Weighted average common shares outstanding, Diluted 1,198,287 923,587